If you are wondering whether Merck's share price still offers value after a strong run, you are not alone. This article is ...

In the latest close session, Merck (MRK) was up +1.14% at $117.11. The stock's performance was ahead of the S&P 500's daily gain of 0.83%. At the same time, the Dow added 0.5%, and the tech-heavy ...

Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Merck shares began peeling back in early 2024, mostly on concerns about looming patent expirations for its breadwinning drug. The trading crowd changed its collective mind a couple months ago, sending ...

Joseph Romanelli, President at Merck & Co (NYSE:MRK), reported an insider buy on January 28, according to a new SEC filing. What Happened: Romanelli made a significant move by purchasing 5,703 shares ...

A giant in the healthcare space, Merck (NYSE:MRK) shares are up 13.5% year-to-date and trading near $119.47, yet retail sentiment on Reddit has slipped from a bullish 63 over the past quarter to a ...

Merck reported breakthrough pivotal Phase 3 results for Keytruda-based combinations in renal cell carcinoma and ovarian cancer. The company also announced positive clinical trial data for a new HIV ...

Merck (MRK) closed the most recent trading day at $106.45, moving +1.13% from the previous trading session. The stock's change was more than the S&P 500's daily gain of 0.19%. At the same time, the ...